Skip to main content

Loading market data...

ADUS

Addus HomeCare Corporation

NASDAQ • United states

$115.16

-$0.82

(-0.71%)

Source: Yahoo Finance · Quote time Oct 19, 2026 20:00 GMT+0000

Management
Credibility
Score

Addus HomeCare Corporation (ADUS)

Unavailable

Quotes may be delayed

$2.15B

Market Cap

130,356

Volume

20.4

P/E Ratio

Unavailable

Div Yield

Addus HomeCare Corporation Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 6303 COWBOYS WAY, FRISCO, TX
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

14 Sep 2026

Addus HomeCare Corporation reported A material agreement

Addus HomeCare Corporation filed an 8-K covering a material agreement, Regulation FD disclosure, supporting financial statements or exhibits.

13 Aug 2026

Addus HomeCare Corporation reported A director or senior management change or compensation event

Addus HomeCare Corporation filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.

4 Aug 2026

Addus HomeCare Corporation filed Form 10-Q

Addus HomeCare Corporation submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

3 Aug 2026

Addus HomeCare Corporation reported Operating or financial results

Addus HomeCare Corporation filed an 8-K covering operating or financial results, Regulation FD disclosure, supporting financial statements or exhibits.

10 Jun 2026

Addus HomeCare Corporation reported Shareholder voting results

Addus HomeCare Corporation filed an 8-K covering shareholder voting results.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$96.95M

Total assets (USD)$1.46B

Total liabilities (USD)$308.33M

Shareholders' equity (USD)$1.15B

Long-term debt (USD)$61.60M

Debt due within a year (USD)$973,000

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$377.42M	$38.94M	$27.61M	$1.49	10-Q · 4 Aug 2026
Q1 2026	$363.61M	$34.07M	$25.07M	$1.36	10-Q · 5 May 2026
Q4 2025	$373.08M	$42.28M	$29.78M	Unavailable	10-K · 24 Feb 2026
Q3 2025	$362.30M	$32.94M	$22.85M	$1.24	10-Q · 4 Nov 2025
Q2 2025	$349.44M	$32.89M	$22.05M	$1.20	10-Q · 5 Aug 2025
Q1 2025	$337.71M	$30.51M	$21.23M	$1.16	10-Q · 6 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $124.86

8.4% upside potential

📈

Strong Buy

Unavailable

👍

Buy

6

⏸️

Hold

2

📉

Sell

1

9 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 20 Oct 2026, 11:47 UTC Targets range 96.00–137.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

22

Jun 2026

Dixon Heather Brianne

President and Chief Operating

Open-market sale

$93.77 per share

288 shares

10

Jun 2026

Hill-Milbourne Veronica

Director

Grant or award

Unavailable per share

1,449 shares

10

Jun 2026

Lopez Esteban

Director

Grant or award

Unavailable per share

1,449 shares

10

Jun 2026

RUSH JEAN

Director

Grant or award

Unavailable per share

1,449 shares

10

Jun 2026

Weaver Susan T

Director

Grant or award

Unavailable per share

1,449 shares

10

Jun 2026

Gordon Darin J.

Director

Grant or award

Unavailable per share

1,449 shares

10

Jun 2026

FIRST MARK L

Director

Grant or award

Unavailable per share

1,449 shares

10

Jun 2026

EARLEY MICHAEL

Director

Grant or award

Unavailable per share

1,449 shares

Top Shareholders

Blackrock, Inc.

3,425,435 shares

10.847% change

6/30/2026

Capital Research Global Investors

1,389,907 shares

-9.471% change

6/30/2026

Vanguard Group Inc

1,308,605 shares

0.809% change

12/31/2025

Dimensional Fund Advisors Lp

835,163 shares

12.234% change

6/30/2026

Vanguard Capital Management Llc

789,325 shares

0.626% change

6/30/2026

State Street Corp

777,826 shares

7.845% change

6/30/2026

Silvercrest Asset Management Group Llc

691,246 shares

-5.204% change

6/30/2026

Wasatch Advisors Lp

627,071 shares

-7.909% change

9/30/2026

American Century Companies Inc

564,637 shares

77.378% change

6/30/2026

Geode Capital Management, Llc

515,525 shares

7.06% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 20 Oct 2026, 11:47 UTC· 1 day ago

Research coverage and investment tools

Addus HomeCare Corporation (ADUS) is a stock listed on the Nasdaq in the United States, in the Health Care sector (Medical/Nursing Services). Its last price was US$115.16 on 19 Oct 2026. That is 75% of the way from its 52-week low of US$87.95 to its 52-week high of US$124.44. Its market capitalisation was US$2.15 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$377.42M	$38.94M	$27.61M	$1.49	32.2%	10.3%	$38.67M	10-Q · 4 Aug 2026 (opens in a new tab)
Q1 2026	$363.61M	$34.07M	$25.07M	$1.36	31.9%	9.4%	$50.65M	10-Q · 5 May 2026 (opens in a new tab)
Q4 2025	$373.08M	$42.28M	$29.78M	Unavailable	33.1%	11.3%	$16.10M	10-K · 24 Feb 2026 (opens in a new tab)
Q3 2025	$362.30M	$32.94M	$22.85M	$1.24	32.2%	9.1%	$49.35M	10-Q · 4 Nov 2025 (opens in a new tab)
Q2 2025	$349.44M	$32.89M	$22.05M	$1.20	32.6%	9.4%	$21.28M	10-Q · 5 Aug 2025 (opens in a new tab)
Q1 2025	$337.71M	$30.51M	$21.23M	$1.16	31.9%	9.0%	$17.07M	10-Q · 6 May 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	8/3/2026	$1.56	$1.51	+3.3%
Mar 2026	5/4/2026	$1.41	$1.33	+6.0%
Dec 2025	2/23/2026	$1.57	$1.53	+2.6%
Sep 2025	11/3/2025	$1.38	$1.35	+2.2%

Cash and equivalents: $96.95M
Total assets: $1.46B
Total liabilities: $308.33M
Shareholders' equity: $1.15B
Long-term debt: $61.60M
Debt due within a year: $973,000

8-K · 14 Sep 2026 · Material agreement Signed

Addus HomeCare Corporation reported A material agreement (opens in a new tab)

Addus HomeCare Corporation filed an 8-K covering a material agreement, Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 13 Aug 2026 · Management change

Addus HomeCare Corporation reported A director or senior management change or compensation event (opens in a new tab)

Addus HomeCare Corporation filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.
10-Q · 4 Aug 2026

Addus HomeCare Corporation filed Form 10-Q (opens in a new tab)

Addus HomeCare Corporation submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 3 Aug 2026

Addus HomeCare Corporation reported Operating or financial results (opens in a new tab)

Addus HomeCare Corporation filed an 8-K covering operating or financial results, Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 10 Jun 2026

Addus HomeCare Corporation reported Shareholder voting results (opens in a new tab)

Addus HomeCare Corporation filed an 8-K covering shareholder voting results.

Insider	Date	Transaction	Shares	Average price	Filing
Dixon Heather Brianne President and Chief Operating	22 Jun 2026	Open-market sale (S)	−288	$93.77	Form 4 (opens in a new tab)
Hill-Milbourne Veronica Director	10 Jun 2026	Grant or award (A)	+1,449	—	Form 4 (opens in a new tab)
Lopez Esteban Director	10 Jun 2026	Grant or award (A)	+1,449	—	Form 4 (opens in a new tab)
RUSH JEAN Director	10 Jun 2026	Grant or award (A)	+1,449	—	Form 4 (opens in a new tab)
Weaver Susan T Director	10 Jun 2026	Grant or award (A)	+1,449	—	Form 4 (opens in a new tab)
Gordon Darin J. Director	10 Jun 2026	Grant or award (A)	+1,449	—	Form 4 (opens in a new tab)
FIRST MARK L Director	10 Jun 2026	Grant or award (A)	+1,449	—	Form 4 (opens in a new tab)
EARLEY MICHAEL Director	10 Jun 2026	Grant or award (A)	+1,449	—	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Blackrock, Inc.	6/30/2026	3,425,435	10.847%
Capital Research Global Investors	6/30/2026	1,389,907	-9.471%
Vanguard Group Inc	12/31/2025	1,308,605	0.809%
Dimensional Fund Advisors Lp	6/30/2026	835,163	12.234%
Vanguard Capital Management Llc	6/30/2026	789,325	0.626%
State Street Corp	6/30/2026	777,826	7.845%
Silvercrest Asset Management Group Llc	6/30/2026	691,246	-5.204%
Wasatch Advisors Lp	9/30/2026	627,071	-7.909%
American Century Companies Inc	6/30/2026	564,637	77.378%
Geode Capital Management, Llc	6/30/2026	515,525	7.06%

Previous close: 115.98 USD
Day range: 114.71 – 116.85 USD
52-week range: 87.95 – 124.44 USD
Volume: 130,356
Market cap: $2.15B
Average volume: 195,501
P/E ratio: 20.4
EPS (FY 2025, diluted): 5.22 USD
Shares outstanding: 18.67M
Beta (5Y monthly): 0.76

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 19 Oct 2026, 20:00 UTC· 2 days ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:40 UTC· 1 hour ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for ADUS yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.